[1]
I. Ljumović, J. Cvijanović, and J. Lazić, “VALUATION OF BIOTECHNOLOGY COMPANIES: REAL OPTIONS APPROACH UNDER UNCERTAINTY”, EA, vol. 59, no. 1, pp. 51–62, Mar. 2012.